127 related articles for article (PubMed ID: 36695080)
1. Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.
Rönsch H; Schiffers F; Ofenloch R; Weisshaar E; Buse AS; Hansen A; John SM; Giménez Arnau AM; Pesqué D; Agner T; Nørreslet LB; Loman L; Romeijn GLE; Schuttelaar MLA; Košćec Bjelajac A; Macan J; Bauer A; Apfelbacher CJ
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1199-1206. PubMed ID: 36695080
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the development of a core domain set for hand eczema trials.
Rönsch H; Apfelbacher C; Brans R; Ofenloch R; Schuttelaar MLA; Weisshaar E; Bauer A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2871-2876. PubMed ID: 32274874
[TBL] [Abstract][Full Text] [Related]
3. [Core outcome measurements in hand eczema trials : The HECOS initiative].
Rönsch H; Bauer A; Apfelbacher C
Hautarzt; 2019 Oct; 70(10):773-777. PubMed ID: 31359075
[TBL] [Abstract][Full Text] [Related]
4. A comparison between self-reported hand eczema and self-reported signs and symptoms of skin lesions indicating hand eczema.
Yüksel YT; Thyssen JP; Nørreslet LB; Flachs EM; Ebbehøj NE; Agner T
Contact Dermatitis; 2022 Dec; 87(6):528-534. PubMed ID: 35808939
[TBL] [Abstract][Full Text] [Related]
5. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
[TBL] [Abstract][Full Text] [Related]
6. Core outcome domains in incontinence-associated dermatitis research.
Van den Bussche K; Kottner J; Beele H; De Meyer D; Dunk AM; Ersser S; Lange T; Petrovic M; Schoonhoven L; Smet S; Van Damme N; Verhaeghe S; Van Hecke A; Beeckman D
J Adv Nurs; 2018 Jul; 74(7):1605-1617. PubMed ID: 29520848
[TBL] [Abstract][Full Text] [Related]
7. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
Simpson RC; Kirtschig G; Selk A; von Seitzberg S; Vittrup G; Bissonnette I; Kottner J; Lanthier J; Stanton C; Foster D; Promm M; Augenti A; Lauretti S; Thomas KS;
Br J Dermatol; 2023 Apr; 188(5):628-635. PubMed ID: 36702803
[TBL] [Abstract][Full Text] [Related]
8. Defining and evaluating novel procedures for involving patients in Core Outcome Set research: creating a meaningful long list of candidate outcome domains.
Smith H; Horobin A; Fackrell K; Colley V; Thacker B; Hall DA;
Res Involv Engagem; 2018; 4():8. PubMed ID: 29507772
[TBL] [Abstract][Full Text] [Related]
9. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study.
Tellum T; Naftalin J; Chapron C; Dueholm M; Guo SW; Hirsch M; Larby ER; Munro MG; Saridogan E; van der Spuy ZM; Jurkovic D
Hum Reprod; 2022 Aug; 37(9):2012-2031. PubMed ID: 35906919
[TBL] [Abstract][Full Text] [Related]
10. Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA; Chalmers JR; Apfelbacher C; Katoh N; Gerbens LAA; Schmitt J; Spuls PI; Thomas KS; Howells L; Williams HC; Simpson EL;
JAMA Dermatol; 2022 Dec; 158(12):1429-1435. PubMed ID: 36223090
[TBL] [Abstract][Full Text] [Related]
11. What is important to people living with dementia?: the 'long-list' of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventions.
Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Lasrado R; Williamson PR; Swarbrick C; Leroi I; Challis D; Hellstrom I; Burns A; Keady J; Reilly ST
BMC Geriatr; 2019 Mar; 19(1):94. PubMed ID: 30917790
[TBL] [Abstract][Full Text] [Related]
12. Core outcome domains for clinical trials in non-specific low back pain.
Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
[TBL] [Abstract][Full Text] [Related]
13. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
[TBL] [Abstract][Full Text] [Related]
14. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
[TBL] [Abstract][Full Text] [Related]
15. Assessment of severity of hand eczema: discrepancies between patient- and physician-rated scores.
van Coevorden AM; van Sonderen E; Bouma J; Coenraads PJ
Br J Dermatol; 2006 Dec; 155(6):1217-22. PubMed ID: 17107392
[TBL] [Abstract][Full Text] [Related]
16. Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.
Kamphuis E; Loman L; Han HL; Romeijn GLE; Politiek K; Schuttelaar MLA
Contact Dermatitis; 2023 May; 88(5):351-362. PubMed ID: 36621910
[TBL] [Abstract][Full Text] [Related]
17. The HOME Core outcome set for clinical trials of atopic dermatitis.
Williams HC; Schmitt J; Thomas KS; Spuls PI; Simpson EL; Apfelbacher CJ; Chalmers JR; Furue M; Katoh N; Gerbens LAA; Leshem YA; Howells L; Singh JA; Boers M;
J Allergy Clin Immunol; 2022 Jun; 149(6):1899-1911. PubMed ID: 35351441
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.
Barrett A; Hahn-Pedersen J; Kragh N; Evans E; Gnanasakthy A
Patient; 2019 Oct; 12(5):445-459. PubMed ID: 31270775
[TBL] [Abstract][Full Text] [Related]
19. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process.
Schmitt J; Langan S; Stamm T; Williams HC;
J Invest Dermatol; 2011 Mar; 131(3):623-30. PubMed ID: 20944653
[TBL] [Abstract][Full Text] [Related]
20. Interventions for chronic pruritus of unknown origin.
Andrade A; Kuah CY; Martin-Lopez JE; Chua S; Shpadaruk V; Sanclemente G; Franco JV
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013128. PubMed ID: 31981369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
